Inventor
ZOLLER MARK J
US19 patents
⚠️ This page may combine multiple inventors who share the name “ZOLLER MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
18 patentsUS5780279AJul 14, 1998
Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
GENENTECH INC198 citations99
US5846765ADec 8, 1998
Identification of novel substrates
GENENTECH INC79 citations96
US5262170ANov 16, 1993
Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
GENENTECH INC22 citations96
US5108901AApr 28, 1992
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC38 citations92
US5770426AJun 23, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC7 citations82
US5616486AApr 1, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC13 citations82
US5520913AMay 28, 1996
Tissue plasminogen activator having zymogenic properties
GENENTECH INC13 citations82
US5411871AMay 2, 1995
Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC10 citations82
US5405771AApr 11, 1995
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations82
US5246850ASep 21, 1993
DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
GENENTECH INC19 citations82
US5840564ANov 24, 1998
Tussue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC4 citations74
US5714145AFeb 3, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations74
US5258180ANov 2, 1993
Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
GENENTECH INC13 citations73
US5728567AMar 17, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US5614190AMar 25, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US5338546AAug 16, 1994
Tissue plasminogen activator variants with decreased clearance
GENENTECH INC4 citations63
US5156969AOct 20, 1992
Tissue plasminogen activator variant with deletion of amino acids 466-470 having fibrin specific properties
GENENTECH INC2 citations62
US5821105AOct 13, 1998
Tissue plasminogen activator having zymognic or fibrin specific properties
GENENTECH INC0 citations52